Heart failure is one of the most serious health problems in the United States today. Millions of people live with this condition, and the number continues to grow as the population ages.
Heart failure does not mean that the heart has completely stopped working. Instead, it means the heart cannot pump blood well enough to meet the body’s needs.
When this happens, the body does not get enough oxygen and nutrients. People with heart failure often feel tired, short of breath, and weak. Many also experience swelling in the legs, feet, or abdomen because fluid builds up in the body.
The condition is also very costly. In the United States alone, heart failure leads to many hospital visits each year and adds billions of dollars to healthcare spending. Doctors and scientists have been working for decades to understand the disease better and to develop treatments that help people live longer and feel better.
Many people think heart failure always means the heart muscle has become weak and cannot pump strongly. This is one common form of the disease, known as heart failure with reduced ejection fraction.
In this case, the heart’s pumping power is lower than normal. Doctors have developed several medications that help patients with this form of heart failure, and one of the most important groups of drugs is called beta‑blockers.
Beta‑blockers work by slowing the heart rate and lowering blood pressure. They also help control abnormal heart rhythms and reduce stress on the heart.
Because of these effects, beta‑blockers have been shown to save lives in patients whose hearts are weak. For this group of people, the drugs are a standard part of treatment and are widely recommended by doctors.
However, heart failure does not always occur because the heart is weak. Another very common form of the disease happens when the heart muscle becomes stiff. In this condition, the heart still pumps with normal strength, but it cannot relax properly between beats.
When the heart cannot relax, it cannot fill with enough blood before pumping again. As a result, less blood moves through the body. This form of the disease is called heart failure with preserved ejection fraction, often shortened to HFpEF.
HFpEF is sometimes described as “stiff heart” heart failure. It is especially common among older adults and people with high blood pressure, diabetes, or obesity.
Unfortunately, doctors still do not have many effective treatments for this form of heart failure. Because of this lack of proven therapies, physicians sometimes prescribe medications that work for the weak‑heart type of failure, even though the two conditions are different.
A new study from researchers at the University of Vermont suggests that one commonly used treatment may not help these patients and could even make their symptoms worse. The research team examined information from a large clinical trial known as the TOPCAT study. This trial included people who had HFpEF and followed their health outcomes over time.
When the researchers analyzed the data, they noticed something surprising. About 80 percent of the patients in the study were taking beta‑blockers.
But people who were using these drugs were much more likely to end up in the hospital because of worsening heart failure. In fact, the analysis showed that patients taking beta‑blockers had a 74 percent higher risk of being hospitalized for heart failure compared with those who were not taking the drugs.
The scientists believe this may happen because the stiff‑heart form of heart failure behaves differently from the weak‑heart form. In HFpEF, the main problem is that the heart muscle does not relax well.
Beta‑blockers slow the heart and change the pressure inside the heart chambers. For people with stiff heart muscle, this may increase pressure in the heart and lungs. That extra pressure can lead to more fluid buildup and stronger symptoms such as shortness of breath and swelling.
The findings do not mean that everyone with HFpEF should immediately stop taking beta‑blockers. Many patients may still need these medications for other reasons, such as high blood pressure, irregular heart rhythms, or previous heart attacks.
However, the study raises an important question about whether the drugs are always the best choice for treating this specific type of heart failure.
The researchers say the results highlight a major gap in medical knowledge. Treatments that work well for one form of heart failure may not work for another. This is why more studies are needed to understand the differences between these conditions and to develop therapies designed specifically for patients with HFpEF.
The research was led by Dr. Timothy Plante and his colleagues at the University of Vermont. Their findings were published in the medical journal JAMA Network Open. The team hopes their work will encourage more careful research into medications for people with stiff‑heart heart failure and lead to better, more personalized treatment strategies in the future.
For patients and families living with heart failure, the study is also a reminder to talk openly with healthcare providers about medications and treatment plans. Understanding the exact type of heart failure a person has can help doctors choose therapies that are most likely to help and avoid treatments that might cause harm.
If you care about heart health, please read studies about how vitamin D influences cholesterol levels, and what we know about egg intake and heart disease.
For more health information, please see recent studies about best supplements for heart disease prevention, and wild blueberries can benefit your heart and brain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
